Journal of
Medicinal Plants Research

  • Abbreviation: J. Med. Plants Res.
  • Language: English
  • ISSN: 1996-0875
  • DOI: 10.5897/JMPR
  • Start Year: 2007
  • Published Articles: 3835

Full Length Research Paper

Cytotoxicity of selected Ethiopian medicinal plants used in traditional breast cancer treatment against breast-derived cell lines

Nigatu Tuasha
  • Nigatu Tuasha
  • Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational, Addis Ababa University, Addis Ababa, Ethiopia.
  • Search for this author on:
  • Google Scholar
Daniel Seifu
  • Daniel Seifu
  • Department of Biochemistry, School of Medicine College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Search for this author on:
  • Google Scholar
Endalamaw Gadisa
  • Endalamaw Gadisa
  • Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.
  • Search for this author on:
  • Google Scholar
Beyene Petros
  • Beyene Petros
  • Department of Microbial, Cellular and Molecular Biology, College of Natural and Computational, Addis Ababa University, Addis Ababa, Ethiopia.
  • Search for this author on:
  • Google Scholar
Stina Oredsson
  • Stina Oredsson
  • Department of Biology, Faculty of Natural Science, Lund University, Lund, Sweden.
  • Search for this author on:
  • Google Scholar


  •  Received: 12 April 2019
  •  Accepted: 10 May 2019
  •  Published: 13 May 2019

Abstract

Traditional medicine is widely practiced in Ethiopia. Here we investigate the toxicity of extracts of seven medicinal plants traditionally used to treat breast cancer in Ethiopia. These plants, Sideroxylon oxyacanthum, Zanthoxylum chalybeum, Clematis simensis, Clematis longicauda, Dovyalis abyssinica, Vernonia leopoldi, and Clerodendrum myricoides, were selected based on recommendations by traditional healers and on the frequency of use. After harvesting the plant material, the water content was determined and the powder was subjected to methanol extraction resulting in crude extracts which were tested for cytotoxicity in dose response assay. Then the methanol extract of the most toxic plants was subjected to further solvent-solvent fractionation to gain petroleum ether, hexane, chloroform, ethyl acetate, and water fractions and these were also tested for cytotoxicity in dose response assays. Extracts of Z. chalybeum and C. myricoides were not toxic. The crude extracts of S. oxyacanthum, C. simensis, and D. abyssinica showed cytotoxicity with half maximal inhibitory concentration 50% (IC50) below 1 μg/ml in the human breast cancer cell lines JIMT-1, MCF-7, and HCC1937. The ethyl acetate fraction of V. leopoldi was the most cytotoxic fraction of all fractions tested with an IC50 of 0.87 μg/ml in JIMT-1 cells. The aqueous fraction of S. oxyacanthum and the chloroform fraction of C. simensis were also cytotoxic. In conclusion, our data show a wide difference in in vitro toxicity of medicinal plants used to treat breast cancer patients, which may guide the use of traditional medicine and the choice of plants for isolation of new compounds for cancer treatment.

Key words: Cancer, Ethiopia, in vitro cytotoxicity, 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT), traditional medicine.

 

Abbreviation

DMSO, Dimethyl sulfoxide; FBS, fetal bovine serum; IC50, half maximal inhibitory concentration 50%; MTT, 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide; PDT, population doubling time; TM, traditional medicine.

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 13 No. 9
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES